17q23.3 de novo microdeletion involving only TANC2 gene: A new case.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 27 05 2020
revised: 25 09 2020
accepted: 31 10 2020
pubmed: 8 11 2020
medline: 2 6 2021
entrez: 7 11 2020
Statut: ppublish

Résumé

Neurodevelopmental disorders (NDDs) show a wide range of overlapping clinical features. Intellectual disability (ID), developmental delay (DD), autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), language and communication disorders with or without motor abnormalities and/or epilepsy have been reported associated to single or multiple genes but in many cases the genetic basis remains unknown. The increasingly use of array-CGH has significantly improved the yield of diagnosing genomic disorders and led to the identification of several novel microdeletion and microduplication syndromes. TANC2 encodes a synaptic scaffold protein interacting with multiple neuropsychiatric disorder-related postsynaptic density (PSD) proteins in dendrites. Here, we describe a new case of TANC2 gene disruption in a 17q23.3 de novo microdeletion identified by array-CGH. The patient presented craniofacial dysmorphic features, hypotonia, and severe cognitive and motor impairment. In conclusion, our data add a further line of evidence supporting the role of TANC2 in NDDs and will help further researches to elucidate the regulatory mechanism of synaptic function and plasticity related to TANC2 haploinsufficiency.

Identifiants

pubmed: 33160097
pii: S1769-7212(20)30804-1
doi: 10.1016/j.ejmg.2020.104094
pii:
doi:

Substances chimiques

Proteins 0
TANC2 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104094

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

E Tassano (E)

Laboratory of Human Genetics, IRCCS Giannina Gaslini, Genoa, Italy. Electronic address: elisatassano@gaslini.org.

A Accogli (A)

Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) - University of Genoa, Genoa, Italy.

P Ronchetto (P)

Laboratory of Human Genetics, IRCCS Giannina Gaslini, Genoa, Italy.

D Tortora (D)

Neuroradiology Unit, IRCCS Giannina Gaslini, Genova, Italy.

E Tavella (E)

Laboratory of Human Genetics, IRCCS Giannina Gaslini, Genoa, Italy.

G Gimelli (G)

Formerly, Laboratory of Cytogenetics, IRCCS Giannina Gaslini, Genoa, Italy.

M Mancardi (M)

Child Neuropsychiatry Unit, IRCCS Giannina Gaslini, Genoa, Italy.

M Malacarne (M)

Laboratory of Human Genetics, IRCCS Giannina Gaslini, Genoa, Italy.

D A Coviello (DA)

Laboratory of Human Genetics, IRCCS Giannina Gaslini, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH